Vice President, Communications

At Johnson & Johnson,we believe health is everything. Our strength in healthcare innovation empowers us to build aworld where complex diseases are prevented, treated, and cured,where treatments are smarter and less invasive, andsolutions are personal.Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.Learn more at jnj.com.

As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world. We provide an inclusive work environment where each person is considered as an individual. At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.

Job Function

Communications & Corporate/External Affairs

Job Sub Function

Multi-Family Communications & Corporate/External Affairs

Job Category

People Leader

All Job Posting Locations

Zug, Switzerland

Job Description

About the role

At Johnson & Johnson, we believe health is everything. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions and profoundly impact health for humanity.

We are seeking an exceptional enterprise leader to serve as Vice President, Communications & Public Affairs (CPA), Europe, Middle East and Africa (EMEA), for Johnson & Johnson Innovative Medicine. This executive role will shape the environment in which our business operates, protect and enhance trust in Johnson & Johnson, and accelerate the region’s most important business, policy, access and reputational priorities.

As the senior CPA leader for EMEA, you will be responsible for the execution of the CPA strategy in the region, translating global business priorities into focused regional and market action, and deploy talent and resources against the highest-value opportunities. You will lead a diverse team including regional, cluster and market CPA leaders, and contribute to build a future-ready function defined by strategic impact, disciplined execution, insight, innovation and measurable outcomes.

You will report to the VP, Global Leader, Johnson & Johnson Innovative Medicine Communications & Public Affairs, serve on the EMEA Innovative Medicine Leadership Team and the global Innovative Medicine CPA Leadership Team, and act as principal strategic counselor to the EMEA Company Group Chair and regional leadership.

This role requires a sophisticated understanding of the diverse geopolitical, healthcare, media and stakeholder landscape across EMEA, combined with the ability to connect global strategy, regional leadership and market execution as one integrated CPA system.

Key Responsibilities and Impact

• Implement CPA strategy aligned with enterprise, global Innovative Medicine and regional business priorities, with clear choices, outcomes and accountability.
• Use geopolitical, policy, stakeholder, reputational, competitive and business intelligence to anticipate shifts, identify opportunities and risks, and influence global and regional decisions.
• Protect and strengthen trust in Johnson & Johnson through proactive reputation leadership, disciplined issues preparedness, and decisive crisis response across markets.
• Drive cross-sector alignment with Johnson & Johnson MedTech and enterprise partners, ensuring consistency on priority reputational topics and presenting one Johnson & Johnson voice where it creates greater impact.

Advance priority Therapeutic Areas, innovation and portfolio leadership

• Align EMEA CPA with global and business priorities and contribute regional insight to the co-creation of global Therapeutic Area strategies, ensuring focus on must-win launches, growth brands, scientific milestones and pipeline opportunities.
• Execute integrated regional strategies across earned, owned, paid, social and digital channels, congresses, campaigns, patient advocacy and stakeholder engagement, using common global platforms with disciplined regional and market activation.
• Strengthen the visibility and relevance of our science and innovation while ensuring communications are differentiated, evidence-based, locally meaningful and compliant.
• Align Communications, Public Affairs, Patient Engagement & Advocacy and business partners around shared outcomes for priority Therapeutic Areas and brands.

Shape policy and access environments to help more patients benefit from innovation

• Execute an integrated EMEA Public Affairs strategy across Therapeutic Areas and above-brand priorities, connecting regional advocacy with global strategy and market action.
• Partner with Market Access, Government